Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Randomized Study of Microlyte - AG Bioresorbable Matrix in the Prevention of Surgical Site Infection After Open Ventral Hernia Repair

NCT05093894 is registered in ClinicalTrials.gov with Prisma Health-Upstate as lead sponsor.

NCT NCT05093894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05093894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Randomized Study of Microlyte - AG Bioresorbable Matrix in the Prevention of Surgical Site Infection After Open Ventral Hernia Repair
Lead sponsor
Prisma Health-Upstate
Phase
Not applicable
Overall status
Withdrawn
Start date
December 14, 2021
Completion date
October 6, 2022
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ventral hernia